Clinical Trial Update: RCT on Bioactive Glass S53P4 in Diabetic Foot Osteomyelitis in the Forefoot (DFORCT) [NA]

View source ↗

Summary

This document reports that a randomized controlled trial evaluating bioactive glass S53P4 for diabetic foot osteomyelitis of the forefoot is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Osteomyelitis
• Osteomyelitis Foot

Drugs mentioned

• Bioactive glass S53P4

Snippet

Sponsor: ASST Ovest Milanese | Conditions: Osteomyelitis - Foot | NA | Status: RECRUITING